Galmed announces results from first-in-man pharmacokinetics study of oral formulation of Aramchol Meglumine (AM) 400mg AM increases bioavailability by ~500% in comparison to Aramchol Free Acid (AA) 300mg

Published: 2026-05-14 08:16:41 ET GLMD

Published on 05/14/2026 at 08:16 am EDT